From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Publication|Articles|March 12, 2026
Pharmacy Practice in Focus: Health Systems
- March 2026
- Volume 15
- Issue 2
Prevalence of Female Authorship in Pharmacy Publishing
Fact checked by: Kelly King
Although the overall proportion of female authors in pharmacy publishing exceeds the representation of women in the pharmacy, medical, and pharmaceutical science workforces, women are more likely to be first authors than senior authors.
Advertisement
Advertisement
Conflicts of interest: This study was not funded. The authors have no financial relationships relevant to the contents of this study to disclose.
Related to this article
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Pharmacy Times featured experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
Advertisement
Advertisement